...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New Zenith MD&A Posted on SEDAR

"If there is a buyout of Zenith Capital Corp the shares used to calculate our share of the proceeds...."

As I understand it, any buyout would be for Zenith Epigenetics rather than Zenith Capital Corp.  That was the point of the 2 companies.  Zenith Cap owns Zenith Ep and we own shares in Zenith Cap.  So if Zenith Ep gets bought, there's no telling what might filter down to us.

Share
New Message
Please login to post a reply